Ulland Investment Advisors’s Neuraxis NRXS Stock Holding History

Ulland Investment Advisors’s Portfolio NRXS Stock Details NRXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7K	Hold	1,000	–	–	﹤0.01%	196
2026 Q2	$7K	Hold	1,000	–	–	0.01%	190
2026 Q1	$7K	Hold	1,000	–	–	0.01%	182
2025 Q4	$5K	Hold	1,000	–	–	﹤0.01%	185
2025 Q3	$3K	Hold	1,000	–	–	﹤0.01%	212
2025 Q2	$2K	Buy	+1,000	New	+$2.34K	﹤0.01%	202

Ulland Investment Advisors's NRXS Position: Q3 2026 in Review

Ulland Investment Advisors held its Neuraxis (NRXS) position steady in Q3 2026 at 1,000 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #196.

Ulland Investment Advisors first reported a position in NRXS in Q2 2025 and has held it in 6 quarters since. 1 fund tracked by Wall St. Rank holds NRXS as of Q3 2026.

Ulland Investment Advisors held 1,000 shares of Neuraxis worth $7K as of Q3 2026.
Ulland Investment Advisors left its Neuraxis share count unchanged in Q3 2026.
Neuraxis made up ﹤0.01% of Ulland Investment Advisors's portfolio in Q3 2026, its #196 holding.
Ulland Investment Advisors first reported a position in Neuraxis in Q2 2025 and has held it in 6 quarters since.
1 fund tracked by Wall St. Rank held Neuraxis as of Q3 2026.

Based on Ulland Investment Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.